Vivani Medical, Inc. (VANI)

NASDAQ: VANI · IEX Real-Time Price · USD
1.850
0.00 (0.00%)
At close: Mar 28, 2024, 4:00 PM
1.900
+0.050 (2.70%)
After-hours: Mar 28, 2024, 6:46 PM EDT

Company Description

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need.

It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.

The company is headquartered in Emeryville, California.

Vivani Medical, Inc.
Vivani Medical logo
Country United States
Founded 1998
IPO Date Nov 19, 2014
Industry Medical Devices
Sector Healthcare
Employees 50
CEO Adam Mendelsohn Ph.D.

Contact Details

Address:
1350 S. Loop Road
Alameda, California 94502
United States
Phone 818-833-5000
Website vivani.com

Stock Details

Ticker Symbol VANI
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001266806
ISIN Number US92854B1098
SIC Code 3845

Key Executives

Name Position
Adam Mendelsohn Ph.D. Co-Founder, Chief Executive Officer and Director
Brigid Ann Makes Chief Financial Officer
Truc Le M.B.A. Chief Operations Officer
Dr. Lisa E. Porter M.D. Chief Medical Officer
Donald Dwyer M.B.A. Chief Business Officer

Latest SEC Filings

Date Type Title
Mar 26, 2024 10-K Annual Report
Mar 26, 2024 8-K Current Report
Mar 6, 2024 8-K Current Report
Mar 5, 2024 8-K Current Report
Mar 5, 2024 424B5 Filing
Mar 5, 2024 144 Filing
Feb 28, 2024 8-K Current Report
Jan 10, 2024 8-K Current Report
Dec 27, 2023 8-K Current Report
Nov 24, 2023 8-K Current Report